Islami Commercial Insurance (DHA:ICICL) Research & Development: BDT0.0 Mil (TTM As of Mar. 2026)


DHA:ICICL Islami Commercial Insurance PLC DHA:ICICL
62 GF Score
Price BDT29.10
GF Value BDT25.40
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Islami Commercial Insurance Research & Development?

Islami Commercial Insurance DHA:ICICL +3.93% 62 Research & Development is BDT0.0 Mil as of Mar. 2026. GuruFocus rates DHA:ICICL with a GF Score™ of 62/100 and a GF Value™ of BDT25.40 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Islami Commercial Insurance's Research & Development for the three months ended in Mar. 2026 was BDT0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was BDT0.0 Mil.

Islami Commercial Insurance  (DHA:ICICL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Islami Commercial Insurance Research & Development Related Terms

Islami Commercial Insurance Research & Development Historical Data

* Premium members only.

The historical data trend for Islami Commercial Insurance's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Islami Commercial Insurance Research & Development Chart

Islami Commercial Insurance Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
0.00 0.00 0.00 0.00 0.00

Islami Commercial Insurance Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
DHA:ICICL
62GF Score
Islami Commercial Insurance PLC DHA:ICICL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Islami Commercial Insurance Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of BDT0.0 Mil mean?
Islami Commercial Insurance (DHA:ICICL) has a Research & Development of BDT0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Islami Commercial Insurance and its competitors.
Is Islami Commercial Insurance's Research & Development too high?
Islami Commercial Insurance's current Research & Development is BDT0.0 Mil. Overall, Islami Commercial Insurance has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Islami Commercial Insurance's Research & Development compare to CB and PGR?
Islami Commercial Insurance's Research & Development of BDT0.0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Islami Commercial Insurance and its competitors. Islami Commercial Insurance's current Research & Development is BDT0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Islami Commercial Insurance stock overvalued right now?
Based on GuruFocus' analysis, Islami Commercial Insurance (DHA:ICICL) is currently considered Modestly Overvalued. The stock's GF Value™ is BDT25.40, compared to a current price of BDT29.10 — trading 14.6% above its estimated fair value. The current Research & Development is BDT0.0 Mil. Islami Commercial Insurance's overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Islami Commercial Insurance (DHA:ICICL), the current Research & Development is BDT0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Islami Commercial Insurance (DHA:ICICL) Overvalued in 2026?

Based on GuruFocus' analysis, Islami Commercial Insurance stock appears to be overvalued. The current stock price of BDT29.10 is trading 14.6% above its estimated GF Value™ of BDT25.40. GuruFocus considers Islami Commercial Insurance to be Modestly Overvalued.

Key valuation signals for DHA:ICICL:

  • Research & Development: BDT0.0 Mil
  • GF Value™: BDT25.40 vs. price of BDT29.10 (14.6% above fair value)
  • GF Score™: 62/100 with 7 warning signs

No single metric tells the full story. See the DHA:ICICL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Islami Commercial Insurance Business Description

Address 90/1, Motijheel C/A, City Center, Level-16, Own Space, Dhaka, BGD, 1000
Islami Commercial Insurance PLC provides the service of non-life (general) insurance solutions such as Fire, Motor, Marine or Miscellaneous Insurance to clients with maximum area coverage. Miscellaneous Insurance includes Burglary Insurance, Fidelity Guarantee, Workmen's Compensation, Personal Accident, Product liability Insurance Policy, and others. The company has four primary business segments for reporting purposes, namely fire, marine, motor, and miscellaneous.
62GF Score

Get the complete analysis for DHA:ICICL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT29.10
Price
BDT25.40
GF Value